{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:09:47Z","timestamp":1771916987748,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.canrad.2022.06.031","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T07:52:01Z","timestamp":1661845921000},"page":"851-857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Radioth\u00e9rapie st\u00e9r\u00e9otaxique des tumeurs primitives h\u00e9patiques\u00a0: indications et nouvelles techniques"],"prefix":"10.1016","volume":"26","author":[{"given":"K.","family":"Bordeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Michalet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Keskes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Debrigode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Azria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Riou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2022.06.031_bib0165","series-title":"Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990\u00a0et 2018. Volume 1\u00a0\u2013\u00a0tumeurs solides","first-page":"372","author":"Defossez","year":"2019"},{"key":"10.1016\/j.canrad.2022.06.031_bib0170","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2022.06.031_bib0175","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2012.05.007","article-title":"A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma","volume":"57","author":"Feng","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0180","first-page":"CD004787","article-title":"Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma","volume":"3","author":"Oliveri","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.canrad.2022.06.031_bib0185","series-title":"Radioth\u00e9rapie en conditions st\u00e9r\u00e9otaxiques des tumeurs h\u00e9patiques","author":"Anon","year":"2016"},{"key":"10.1016\/j.canrad.2022.06.031_bib0190","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prro.2021.09.004","article-title":"External beam radiation therapy for primary liver cancers: an ASTRO clinical practice guideline","volume":"12","author":"Apisarnthanarax","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0195","doi-asserted-by":"crossref","first-page":"101590","DOI":"10.1016\/j.clinre.2020.101590","article-title":"Hepatocellular carcinoma: French intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, Gercor, Unicancer, SFCD, SFED, SFRO, Afef, Siad, SFR\/FRI)","volume":"45","author":"Blanc","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0200","series-title":"Anon, th\u00e9saurus national de canc\u00e9rologie digestive","article-title":"Cancer des voies biliaires","author":"Malka","year":"2019"},{"key":"10.1016\/j.canrad.2022.06.031_bib0205","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022\u00a0update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.radonc.2018.12.005","article-title":"Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: a systematic review and meta-analysis of observational studies","volume":"131","author":"Rim","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0215","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.canrad.2021.08.013","article-title":"Hepatic tumours and radiotherapy","volume":"26","author":"Rio","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2022.06.031_bib0220","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1245\/s10434-007-9627-x","article-title":"Surgical management of intrahepatic cholangiocarcinoma\u00a0\u2013\u00a0a population-based study","volume":"15","author":"Tan","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1200\/JCO.2015.61.3778","article-title":"Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysis","volume":"34","author":"Tao","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0230","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.canrad.2017.07.040","article-title":"Radioth\u00e9rapie en conditions st\u00e9r\u00e9otaxiques des tumeurs h\u00e9patiques\u00a0: \u00e9tat de l\u2019art","volume":"21","author":"Riou","year":"2017","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2022.06.031_bib0235","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.canrad.2019.07.159","article-title":"Radioth\u00e9rapie st\u00e9r\u00e9otaxique h\u00e9patique\u00a0: particularit\u00e9s cliniques et implications techniques, r\u00e9sultats. Quelle machine pour quelle situation\u00a0?","volume":"23","author":"Riou","year":"2019","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2022.06.031_bib0240","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.3390\/cancers13194853","article-title":"Image-guided liver stereotactic body radiotherapy using VMAT and real-time adaptive tumor gating: evaluation of the efficacy and toxicity for hepatocellular carcinoma","volume":"13","author":"Cantaloube","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canrad.2022.06.031_bib0245","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.semradonc.2014.02.008","article-title":"The ViewRay system: magnetic resonance-guided and controlled radiotherapy","volume":"24","author":"Mutic","year":"2014","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0250","first-page":"54","article-title":"Adaptive radiotherapy: the Elekta Unity MR-linac concept","volume":"18","author":"Winkel","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0255","doi-asserted-by":"crossref","first-page":"616027","DOI":"10.3389\/fonc.2021.616027","article-title":"MR-guided radiotherapy for liver malignancies","volume":"11","author":"Boldrini","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0260","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijrobp.2005.12.042","article-title":"Abdominal organ motion measured using 4D CT","volume":"65","author":"Brandner","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.031_bib0265","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.ijrobp.2007.11.042","article-title":"Comparison of different strategies to use four-dimensional computed tomography in treatment planning for lung cancer patients","volume":"70","author":"Wolthaus","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.031_bib0270","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijrobp.2015.10.015","article-title":"Online magnetic resonance image guided adaptive radiation therapy: first clinical applications","volume":"94","author":"Acharya","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.031_bib0275","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13014-020-01641-0","article-title":"Treatment plan quality during online adaptive replanning","volume":"15","author":"van Timmeren","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0280","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S1470-2045(20)30034-6","article-title":"MRI-guided adaptive radiotherapy for liver tumours: visualising the future","volume":"21","author":"Witt","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0285","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-020-03480-8","article-title":"MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach","author":"Boldrini","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0290","first-page":"e5774","article-title":"Real-time magnetic resonance-guided liver stereotactic body radiation therapy: an institutional report using a magnetic resonance-linac system","volume":"11","author":"Feldman","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.canrad.2022.06.031_bib0295","doi-asserted-by":"crossref","first-page":"e0236570","DOI":"10.1371\/journal.pone.0236570","article-title":"Initial clinical experience of stereotactic body radiation therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5\u00a0Tesla MR-Linac","volume":"15","author":"Hall","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.canrad.2022.06.031_bib0300","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","article-title":"Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen","volume":"126","author":"Henke","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0305","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.adro.2019.09.008","article-title":"Clinical outcomes using magnetic resonance-guided stereotactic body radiation therapy in patients with locally advanced cholangiocarcinoma","volume":"5","author":"Luterstein","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0310","first-page":"142","article-title":"A multi-institutional experience of mr-guided liver stereotactic body radiation therapy","volume":"4","author":"Rosenberg","year":"2019","journal-title":"Adv RadiatOncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2021.06.005","article-title":"Ablative radiotherapy for liver tumors using stereotactic MRI-guidance: a prospective phase I trial","volume":"170","author":"van Dams","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.06.031_bib0160","doi-asserted-by":"crossref","first-page":"610637","DOI":"10.3389\/fonc.2021.610637","article-title":"Magnetic resonance-guided stereotactic body radiotherapy of liver tumors: initial clinical experience and patient-reported outcomes","volume":"11","author":"Weykamp","year":"2021","journal-title":"Front Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:36:20Z","timestamp":1761136580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321822001329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":32,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1278321822001329"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2022.06.031","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radioth\u00e9rapie st\u00e9r\u00e9otaxique des tumeurs primitives h\u00e9patiques\u00a0: indications et nouvelles techniques","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2022.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}